Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03741920 · ClinicalTrials.gov registry record · NA
Evaluation of the Personal KinetiGraph™ (PKG™) to Improve Insight Into Parkinson's Disease Status
A NA study of Parkinson Disease, sponsored by Global Kinetics Corporation.
- Active
- Registry status
- NA
- Development phase
- 231
- Enrollment target
- 12
- Study locations
NCT03741920 is a NA study of Parkinson Disease that is active but no longer recruiting, run by Global Kinetics Corporation. The registered enrollment target is 231 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (96% lower). The trial reports 12 study locations across 7 states.
The verdict
NCT03741920, a NA study of Parkinson Disease, is active but no longer recruiting, sponsored by Global Kinetics Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 231 participants
- Enrollment target
- 12
- Study locations
Study Summary
The primary objective is to understand the utility of Personal KinetiGraph movement recording system data in the clinical management of Parkinson's disease (PD) in routine clinical care at a movement disorders clinic. Specifically: 1. Measure medication use and clinical management plan changes in a large, multicenter cohort among participants undergoing a clinical assessment with an MDS in which the MDS reviews the participant's PKG during the clinical assessment in half of the enrolled participants (PKG + Group) and in half of the enrolled participants the MDS completes the clinical assessment without the PKG (PKG- Group). 2. Determine the association between frequency of medication changes, the PKG information, and other clinical assessments among participants with and without a PKG report of their PD motor status available to the clinician at the time of evaluation.
Conditions Studied
Interventions
- DEVICE Personal KinetiGraph™ (PKG™)
Study Locations (12)
Florida
- Parkinson's Disease and Movement Disorders Center - Boca Raton
- University of Florida - Gainesville
- University of Miami - Miami
- University of South Florida - Tampa
California
- Sutter Health - Sacramento
- University of California - San Diego
New York
- Northwell Health - Great Neck
- New York University - New York
Kansas
- University of Kansas Medical Center - Kansas City
Maryland
- Johns Hopkins Medical Institute - Baltimore
Michigan
- Michigan State University - East Lansing
Texas
- University of Texas - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 231 participants |
| Start Date | 2017-05-17 |
| Est. Completion | 2025-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03741920
The ClinicalTrials.gov registry entry for NCT03741920 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 231 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (96% lower). The listed sponsor is Global Kinetics Corporation, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Personal KinetiGraph™ (PKG™) is the first listed.
NCT03741920 reports 12 study locations spanning 7 distinct geographic areas - top geographies include Florida, California, New York.
Frequently Asked Questions
What is clinical trial NCT03741920 about?
NCT03741920 is a clinical study titled "Evaluation of the Personal KinetiGraph™ (PKG™) to Improve Insight Into Parkinson's Disease Status". The primary objective is to understand the utility of Personal KinetiGraph movement recording system data in the clinical management of Parkinson's disease (PD) in routine clinical care at a movement disorders clinic. Specifically: 1. Measure medication use and clinical management plan changes in a...
What is the current status of trial NCT03741920?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 231 participants. The study started on 2017-05-17. Estimated completion is 2025-10.
What conditions does trial NCT03741920 study?
This clinical trial studies the following conditions: Parkinson Disease.
What interventions are being tested in trial NCT03741920?
The interventions under investigation include: Personal KinetiGraph™ (PKG™) (DEVICE).
Who is sponsoring clinical trial NCT03741920?
This trial is sponsored by Global Kinetics Corporation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03741920 being conducted?
This trial has 12 study locations across California, Florida, Kansas, Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Neurophysiology of Reward Signaling in Parkinson's Disease
RECRUITING · NA
-
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
RECRUITING · NA
-
Rock Steady Boxing: A Community Based In Person Class
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.